Skip to content

A Randomised Controlled Trial of Hysteroscopic Resection of Mild Septum/Arcuate Uteri.

A Randomised Controlled Trial of Hysteroscopic Resection of Mild Septum/Arcuate Uteri in Women With Recurrent Miscarriage.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03384082
Enrollment
82
Registered
2017-12-27
Start date
2019-02-22
Completion date
2022-01-01
Last updated
2020-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arcuate Uterus

Brief summary

At least 82 cases of recurrent miscarriage women with a diagnosis of arcuate uterus, confirmed by three-dimensional intra-vaginal sonography (3D-TVS) and hysteroscopy, will be recruited. The subjects will be randomly divided into two groups, the experimental group will be given hysteroscopic treatment, the control group will receive no treatment. The pregnancy rates (\>12 weeks) of the two groups will befollowed and compared.

Detailed description

This study will be carried out at the Hysteroscopy center of the Fuxing Hospital, Beijing, China. At least 82 recurrent miscarriage women with a diagnosis of arcuate uterus who had unexplained recurrent spontaneous abortion (less than 12 weeks) before and have fertility requirement will be recruited. The patients will be explained the study and sign the informed consent. According to the random number table, the corresponding cases were divided into treatment group and control group. The experimental group will be given hysteroscopic treatment, the control group will receive no treatment. The follow up of the spontaneous abortion rate and the pregnancy rate of two groups will be screened within 1-2 years and the correlation between the arcuate uterus and recurrent miscarriage will be analyzed.

Interventions

PROCEDUREhysteroscopic treatment

treatment

Sponsors

Fu Xing Hospital, Capital Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1. Women with arcuate/mild septum uteri 2. Women with unexplained recurrent miscarriage (less than 12 weeks) 3. Having a second time fertility requirement 4. Having Informed consent before entering this study, and be willing to receive hysteroscopic treatment

Exclusion criteria

1. 3D-TVS and hysteroscopy suggest uterine fibroids (submucosal and III type uterine fibroids, intramural fibroids,the diameter of whichis greater than 4cm), adenomyosis, endometrial polyps, intrauterine adhesions and other uterine factors that may lead to spontaneous abortion 2. Endometrial pathological diagnosis of chronic endometritis, endometrial hyperplasia and endometrial cancer 3. Ultrasound or HSG suggest hydrosalpinx 4. Chromosome abnormalities of the couples, positive findings of pre-thrombosis state and the detection of immunity, uterine malformation, uterine fibroids, adenomyosis and other uterine factors causing recurrent miscarriage 5. Semen abnormality in male 6. FSH \> 10

Design outcomes

Primary

MeasureTime frameDescription
The pregnancy rate(>12 weeks)of the two groups2 yearsThe pregnancy rate(\>12 weeks) of the two groups after receiving hysteroscopic treatment and no treatment.
The spontaneous abortion rate of the two groups2 yearsThe spontaneous abortion rate of the two groups after receiving hysteroscopic treatment and no treatment.
The live birth rate of the two groups2 yearsTe live birth rate of the two groups after receiving hysteroscopic treatment and no treatment.

Countries

China

Contacts

Primary ContactDongmei Song, Ph.D
echosdm@163.com88062220
Backup ContactYu Xiao, Ph.D

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026